ELLEN DILLARD: Open Payments
NPI 1568016244 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,121 in 84 payments from 14 companies in 2025. Trend: 2023 $32,845 · 2024 $53,748 · 2025 $35,121
Speaker / faculty: $22,471Travel & lodging: $7,226Food & beverage: $3,078Consulting: $2,250Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 60 | $33,690 |
| E.R. Squibb & Sons, L.L.C. | 2 | $257 |
| PFIZER INC. | 1 | $181 |
| SANOFI-AVENTIS U.S. LLC | 3 | $175 |
| BeiGene USA, Inc. | 1 | $144 |
| Syndax Pharmaceuticals, Inc. | 3 | $136 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| Alnylam Pharmaceuticals Inc. | 3 | $108 |
| Lilly USA, LLC | 1 | $95 |
| Novartis Pharmaceuticals Corporation | 2 | $94 |
Products named: RYBREVANT, DARZALEX, REBLOZYL, REZUROCK, BRUKINSA, OJJAARA, REVUFORJ, AMVUTTRA.
Industry payments across MI — which companies pay providers there.
